DoubleLine
2009
FOUNDED
PRIVATE
STATUS
101-200
EMPLOYEES
PE Growth
LATEST DEAL TYPE
1
FINANCING ROUNDS
2
INVESTMENTS
Description
Operator of an investment management firm intended to deliver better risk-adjusted returns to the client. The company's investment policy includes security selection, trade execution, portfolio construction, sector allocation, risk analysis. It provides asset management, investment, and risk management related services.
Website
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Asset Management
Other Industries
Other Financial Services
Primary Office
- 333 South Grand Avenue
- Los Angeles, CA
- United States
+1 (213) 000-0000
DoubleLine Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore DoubleLine‘s full profile, request access.
Request full access to PitchBookDoubleLine Competitors (38)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| OppenheimerFunds | Corporate Backed or Acquired | Denver, CO | 0000 | 000000&0 | ||
| 0000000 | Formerly PE-Backed | Hartford, CT | 000 | 00000 | 000000&0 | |
| 00000 00000 000000 | Private Equity-Backed | Newtown, PA | 00 | 00.00 | 00000000000 | 00.00 |
| 0000000 0000000000 | Corporate Backed or Acquired | Newport Beach, CA | 0000 | 00000 | 000000000 | 00000 |
| 00000 00000 | Corporation | New York, NY | 0 | 0000000000 |
DoubleLine Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000 000000000000 | 11-Aug-2015 | 00000 00000 00 | 0000 | Drug Discovery | |
| Ovid Therapeutics | 16-Mar-2015 | Early Stage VC | 00.000 | Drug Discovery |
DoubleLine Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000 000000000000 | 11-Aug-2015 | 00000 00000 00 | 0000 | Completed |
|
| Ovid Therapeutics | 16-Mar-2015 | Early Stage VC | 00.000 | Completed |
DoubleLine Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore DoubleLine‘s full profile, request access.
Request full access to PitchBook